Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Innovation is increasingly intertwined with advancements in ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

K-12 education can benefit from AI’s synthesis of research and curriculum standards. Industrial Research Looks Into the Future, and You Can Too! A report out this month from IRI–one of a handful of ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

On May 2, 2024, Japanese prime minister Kishida Fumio announced the launch of the Hiroshima AI Process Friends Group at the Meeting of the Council at Ministerial Level (MCM) of the Organisation for ...